CD127/IL-7Rα Antagonist
Showing 1 - 25 of 4,142
Memory CD8+ T Cells With Sepsis Severity and
Recruiting
- Sepsis
- Inflammatory Response
-
Wuhan, Hubei, ChinaDepartment of Critical Care Medicine, Union Hospital, Tongji Med
May 16, 2023
Immunophenotypic Evaluation of IL-7R a in Acute Leukaemia
Not yet recruiting
- Benefit: To Patient Have Investigation for Diagnosis and Follow up for His Disease and Reach to New Method Help in Early Diagnosis of Lymphoid Disorder
- (no location specified)
Nov 30, 2022
Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)
Recruiting
- Adamantinomatous Craniopharyngioma
- Recurrent Adamantinomatous Craniopharyngioma
-
Aurora, Colorado
- +17 more
Jan 8, 2023
Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis
Not yet recruiting
- Rheumatoid Arthritis
- (no location specified)
Oct 4, 2022
Metastatic Melanoma Trial in New Haven (Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab)
Terminated
- Metastatic Melanoma
- Tumor Infiltrating Lymphocytes
- Nivolumab and Ipilimumab
-
New Haven, ConnecticutYale New Haven Hospital
Jul 20, 2022
Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)
Not yet recruiting
- Lupus Nephritis
- Type 1 Diabetes Mellitus
- autologous adoptive T regulatory cell transfer.
-
Cairo, EgyptAin shams university, faculty of medicine
Sep 30, 2022
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
Vitamin d Deficiency Trial in Nîmes (Vitamin D, Placebo)
Not yet recruiting
- Vitamin d Deficiency
- Vitamin D
- Placebo
-
Nîmes, FranceCHU de Nîmes
Dec 8, 2022
Differentiate Statuses of Periodontitis
Active, not recruiting
- Periodontitis
-
Baghdad, IraqUniversity of Baghdad
Feb 1, 2023
Healthy Subjects Trial in Antwerp (OSE-127, Placebo)
Completed
- Healthy Subjects
- OSE-127
- Placebo
-
Antwerp, BelgiumSGS Life Sciences (SGS LS), Clinical Pharmacology Unit (CPU)
Dec 10, 2019
Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Kineret 100 MG in 0.67 ML Prefilled Syringe
- +3 more
-
Frankfurt, GermanyUniversity Hospital Goethe University Frankfurt
Aug 23, 2022
Interleukin-6 Inhibition, Physical Stress, Appetitive Behavior Trial in Copenhagen Ø (Tocilizumab Injectable Product, Saline
Completed
- Interleukin-6 Inhibition
- +2 more
- Tocilizumab Injectable Product
- Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour
-
Copenhagen Ø, DenmarkCenter For Physical Activity (CFAS)
Aug 19, 2022
Mycobacterium Infections, Nontuberculous Trial in Saint Louis (Recombinant human interleukin-7)
Recruiting
- Mycobacterium Infections, Nontuberculous
- Recombinant human interleukin-7
-
Saint Louis, MissouriWashington University
Mar 30, 2022
Postprandial Hypoglycemia Trial in Basel (empagliflozin, anakinra, saline subcutaneous (s.c.) ())
Recruiting
- Postprandial Hypoglycemia
- empagliflozin
- +3 more
-
Basel, SwitzerlandDepartment of Endocrinology, Diabetes and Metabolism, University
Apr 19, 2022
Type 1 Diabetes Trial in San Francisco, New Haven (PolyTregs+IL-2)
Completed
- Type 1 Diabetes Mellitus
- PolyTregs+IL-2
-
San Francisco, California
- +1 more
Oct 15, 2021
COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)
Recruiting
- COVID-19
- Hospitalized COVID-19 Patients
- Lopinavir / Ritonavir
- +3 more
-
Zgharta, North, Lebanon
- +1 more
Jun 28, 2023
Relapsed and/or Refractory B-cell Lymphoma Trial in Stanford, Baltimore, Houston (Cyclophosphamide, Fludarabine, KITE-363)
Recruiting
- Relapsed and/or Refractory B-cell Lymphoma
- Cyclophosphamide
- +2 more
-
Stanford, California
- +2 more
Aug 16, 2022
MDD Trial (Tocilizumab, Placebo, Whole-Body Hyperthermia)
Not yet recruiting
- Major Depressive Disorder
- Tocilizumab
- +2 more
- (no location specified)
Aug 23, 2022
HIV, Inflammatory Markers, Colchicine Adverse Reaction Trial in Ratchathewi (Low-dose colchicine, Placebo)
Recruiting
- HIV Infections
- +2 more
- Low-dose colchicine
- Placebo
-
Ratchathewi, ฺBangkok, ThailandAngsana Phuphuakrat
Dec 20, 2021
Benign Prostatic Hyperplasia (BPH) Trial in Glenview (Adalimumab)
Not yet recruiting
- Benign Prostatic Hyperplasia (BPH)
-
Glenview, IllinoisNorthShore University HealthSystem
Sep 25, 2023
End-Stage Renal Disease Trial in United States (Anakinra, Placebo)
Completed
- End-Stage Renal Disease
- Anakinra
- Placebo
-
Washington, District of Columbia
- +3 more
Jan 19, 2022
Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain
Recruiting
- Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
- Quantitative Real Time Polymerase chain reaction (qRT-PCR)
- ELISA and colorimeter
-
Assiut, EgyptBiochemistry department,Faculty of medicine
Oct 10, 2023
IL-23-Responsive Immune Cell Subsets in Post-Operative
Recruiting
- Crohn´s Disease
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC
Aug 16, 2023
Asthma; Eosinophilic Trial (Mepolizumab 100 MG)
Recruiting
- Asthma
- Eosinophilic Asthma
- Mepolizumab 100 MG
-
Ferrol, A Coruña, Spain
- +4 more
Sep 5, 2022